Article
Contribution of adiponectin to the cardiometabolic risk of postmenopausal women with loss-of-function lipoprotein lipase gene mutations.
Menopause (New York, N.Y.) - 1 May 2011
Loucif Yacine, Méthot Julie, Tremblay Karine, Brisson Diane, Gaudet Daniel
Abstract excerpt
OBJECTIVE: Cardiovascular risk significantly increases after menopause. Lipoprotein lipase (LPL) is a key enzyme in the metabolism of triglyceride (TG)-rich lipoproteins, which contributes to cardiometabolic homeostasis. Adiponectin is an adipocytokine, which also influences the cardiometabolic status. The objective of this study was to evaluate the contribution of plasma adiponectin to the cardiometabolic status...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
